- Bay Area Times
- Posts
- China raises tariffs against U.S. to 125%, but will ignore further tariff raises
China raises tariffs against U.S. to 125%, but will ignore further tariff raises
Bay Area Times
April 11, 2025
Brought to you by:
Top stories today:
- China raises tariffs on U.S. to 125%, but will ignore further tariff raises
- ChatGPT can now reference your past chats for personalized responses
- TikTok fuels ByteDance’s record $39B in international revenue in 2024
- CPI, Core CPI slow down more than expected ahead of tariffs impact
- Elon cuts DOGE savings estimate to $150B for FY2026, down from $1T
- U.S. service exports overlooked by Trump’s tariff move
0. Data and calendar
All values as of 6 AM ET / 3 AM PT, other than S&P500 and NASDAQ close (4 PM ET / 1 PM PT).
All times are ET.
Listen to our AI-generated podcast summarizing today’s newsletter (beware of hallucinations):
1. China raises tariffs against U.S. to 125%, but will ignore further tariff raises
Effective from Apr. 12 and applicable to all U.S. goods.
Up from the 84% tariffs announced earlier.
China’s Xi Jinping will host EU leaders in July: report.
Trump admits “transition problems” with China tariffs at 145%.
Over 365 million people worldwide suffer from osteoarthritis and there's still no cure, just painkillers and ice packs.
Cytonics’ CYT-108 is a lab-tweaked version of a natural protein (A2M) that blocks the enzymes that eat away at cartilage.
Backed by NIH grants and over 6,000 shareholders, Cytonics is now letting the public invest in its next clinical trial phase.
It’s a shot at finally treating the root cause of joint pain, not just managing it.
*Sponsored by Cytonics ($50,000 contracted). Prospective investors should review the offering materials for details, including all risk factors, before making an investment decision. Any investment involves significant risks, including the potential loss of the total investment. This advertisement is not an offer to sell or a solicitation of an offer to buy securities. This Reg A+ offering is made available through StartEngine Primary, LLC. This investment is speculative, illiquid, and involves a high degree of risk, including the possible loss of your entire investment. Please read the offering circular before investing in Cytonics.
3. ChatGPT can now reference your past chats for personalized responses
Rolling out first to ChatGPT Pro and Plus subscribers, except for those in the U.K., EU, Iceland, Liechtenstein, Norway, and Switzerland.
Will add conversational context to text, voice, and image-generation features.
An opt-out is available through ChatGPT’s settings.
4. TikTok said to fuel ByteDance’s record $39B in international revenue in 2024
